Navigation Links
Alexza Pharmaceuticals Updates Staccato® Pipeline and Outlines Pipeline Development Strategy
Date:7/12/2010

we believe will be a series of development programs over the next 12 to 18 months."

About Alexza Pharmaceuticals, Inc.

Alexza Pharmaceuticals is a pharmaceutical company focused on the research, development and commercialization of novel, proprietary products for the acute treatment of central nervous system conditions.  Alexza's technology, the Staccato system, vaporizes unformulated drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery through deep lung inhalation.  The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience. (Click here to see an animation of how the Staccato system works.)

AZ-004 (Staccato loxapine) is Alexza's lead program, which is being developed for the rapid treatment of agitation in schizophrenic or bipolar disorder patients.  Alexza has completed and announced positive results from both of its AZ-004 Phase 3 clinical trials, submitted a New Drug Application in December 2009, and has a Prescription Drug User Fee Act (PDUFA) goal date of October 11, 2010.  In February 2010, Alexza established a partnership with Biovail Laboratories International SRL, a subsidiary of Biovail Corporation, to develop and commercialize AZ-004 in the U.S. and Canada.  For more information about Alexza, the Staccato technology or the Company's de
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Alexza Pharmaceuticals to Present at Jefferies 2010 Global Life Sciences Conference
2. Alexza Secures $25 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd.
3. Alexza Pharmaceuticals to Present at The Ninth Annual JMP Securities Research Conference
4. Alexza Executes $15 million Working Capital Loan with Hercules Technology Growth Capital, Inc.
5. Alexza Pharmaceuticals Files Shelf Registration Statement
6. Alexza to Announce 2010 First Quarter Financial Results on Monday, May 10, 2010
7. Alexza Reports 2009 Fourth Quarter and Full Year Financial Results and Provides General Corporate Update
8. Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller
9. Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010
10. Alexza Announces AZ-004 (Staccato(R) Loxapine) PDUFA Goal Date of October 11, 2010
11. Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014  Amerigen Pharmaceuticals Ltd. announces ... Ltd., has received Chinese FDA (CFDA) approval and ... Tablets into the China ... and distribution agreement with Sinochem Jiangsu Pharmaceutical Co., ... US FDA approved and China CFDA certified oral ...
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com announces ... in its catalogue: The Market for ... The European, Middle Eastern and African ... devices. As part of its coverage, this study: ... on the EMEA medical device markets and estimates ...
(Date:8/20/2014)... , Aug. 20, 2014 ... research report is available in its catalogue: ... Records http://www.reportlinker.com/p0833392/EMR-2014-The-Market-for-Electronic-Medical-Records.html ... for electronic medical records (EMR) for nearly a ... report of our findings. Our report has become ...
Breaking Medicine Technology:Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into the China domestic mark 2The Market for Medical Devices in EMEA 2The Market for Medical Devices in EMEA 3The Market for Medical Devices in EMEA 4The Market for Medical Devices in EMEA 5EMR 2014: The Market for Electronic Medical Records 2EMR 2014: The Market for Electronic Medical Records 3EMR 2014: The Market for Electronic Medical Records 4EMR 2014: The Market for Electronic Medical Records 5EMR 2014: The Market for Electronic Medical Records 6EMR 2014: The Market for Electronic Medical Records 7EMR 2014: The Market for Electronic Medical Records 8
... April 25, 2011 The 2010 Pharmacy Today ... American Pharmacists Association , reveals pharmacists believe that ... was recommended by their pharmacist, 92% of pharmacists walk ... a product selection and the average patient consult takes ...
... Scientific Corporation (NYSE: BSX ) today ... and launch of the ION™ Paclitaxel-Eluting Platinum Chromium ... technology.  The ION Stent System incorporates a unique ... stenting and intended to improve the acute performance ...
Cached Medicine Technology:Pharmacists Offer Guidance on Top Over-The-Counter Medications 2Pharmacists Offer Guidance on Top Over-The-Counter Medications 3Boston Scientific Announces FDA Approval and U.S. Launch of ION™ Platinum Chromium Stent System 2Boston Scientific Announces FDA Approval and U.S. Launch of ION™ Platinum Chromium Stent System 3Boston Scientific Announces FDA Approval and U.S. Launch of ION™ Platinum Chromium Stent System 4Boston Scientific Announces FDA Approval and U.S. Launch of ION™ Platinum Chromium Stent System 5
(Date:8/20/2014)... Angeles, CA (PRWEB) August 20, 2014 ... it is bringing on Wrench Advisors as a ... tasks including international large accounts. , As Wrench ... sales consultants can help your organization plan and ... executives and global distribution channels. Our experience developing ...
(Date:8/20/2014)... 20, 2014 Business owners looking for ways ... a big, lasting impact – should check out the latest ... http://www.PerWickstrom.com . , The new blog post, which is ... Your Business,” highlights that:, , Opportunities for ... and therefore it’s essential to be alert and focused. , ...
(Date:8/20/2014)... TX (PRWEB) August 20, 2014 Texas Medical ... new study. The study will help test the effectiveness of ... suffer from high cholesterol may be eligible to participate in ... much cholesterol in the blood can lead to cardiovascular disease, ... Lowering cholesterol can help reduce the risk of heart disease ...
(Date:8/20/2014)... the 100th anniversary of a revolutionary technique that underpins ... (C&EN) magazine last week released a special edition ... tantalizing glimpse of its future. C&EN is the weekly ... world,s largest scientific society. , The technique got its ... first paper on X-ray diffraction from a crystal in ...
(Date:8/20/2014)... services from the Veterans Health Administration finds general satisfaction, ... studied. , The RAND Corporation study, conducted in 2008 ... disorder were less satisfied than other veterans who received ... were less likely than others to report that staff ... findings, published in the journal Psychiatric Services , ...
Breaking Medicine News(10 mins):Health News:Biocide Systems Announces Partnership with Wrench Advisors 2Health News:Per Wickstrom’s Latest Blog Post Focuses on Small Changes that Can Have a Big Impact on Business 2Health News:Texas Medical Research Associates Announce New Study 2Health News:Survey finds veterans generally satisfied with mental health care 2
... HealthDay Reporter , WEDNESDAY, July 20 (HealthDay News) ... rashes, but the similarities between the two common, distressing ... patients suffering from both ailments (a very rare phenomenon), ... responses that prompt skin flare-ups for both diseases. ...
... Mann HealthDay Reporter , WEDNESDAY, July 20 (HealthDay ... may be heating up. New technology promises to cut costs ... all of your genes and potentially provide a personalized report ... The human genome was first mapped in 2001 and ...
... health, alleviate hunger, raise living standards and empower women ... to play. Jagdev Sharma, a researcher ... Arizona State University,s Biodesign Institute has been investigating the ... villagers in rural Uganda. He reports his findings this ...
... the Breast Health Center at Women & Infants Hospital ... earn a 2011 Breast Cancer Symposium Merit Award from ... Clinical Oncology (ASCO). The award, which recognizes researchers, ... Shannon MacLaughlan, MD, who is also affiliated with The ...
... injuring a muscle through an accident like falling off a ... serious complication. Their muscles start growing bones. ... there was no treatment. But now, research from Northwestern University ... at the University of Pennsylvania shows that a neuropeptide in ...
... American Society for Radiation Oncology (ASTRO) has awarded ... Faculty Career Research Training Award and the Residents/Fellows ... were selected by ASTRO,s Research Evaluation Committee. ... awarded to stimulate interest in radiation research early ...
Cached Medicine News:Health News:Scientists Close in on Origins of Psoriasis, Eczema 2Health News:Scientists Close in on Origins of Psoriasis, Eczema 3Health News:Cheaper DNA Sequencing Coming Closer 2Health News:Cheaper DNA Sequencing Coming Closer 3Health News:A new breed: Highly productive chickens help raise Ugandans from poverty 2Health News:A new breed: Highly productive chickens help raise Ugandans from poverty 3Health News:When injured muscles mistakenly grow bones 2
Sedillot periosteal elevator, 16 mm, sharp, 7"....
Periosteal elevator #9H, 17.5 cm, 7"....
Obwegeser periosteal elevator, angled, 9 mm, 20 cm, 8"....
... The Anterior Isola System is ... scoliotic, lordotic or kyphotic spinal ... stiff fixation bridge parallel to ... spine. The system, developed for ...
Medicine Products: